+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lymphoma Drugs Market Research Reports

From
abexinostat - Product Thumbnail Image

abexinostat

  • Report
  • 14 Pages
From
Calquence - Product Thumbnail Image

Calquence

  • Report
  • 16 Pages
From
INCB050465 - Product Thumbnail Image

INCB050465

  • Report
  • 16 Pages
From
Betalutin - Product Thumbnail Image

Betalutin

  • Report
  • 17 Pages
From
Aliqopa - Product Thumbnail Image

Aliqopa

  • Report
  • 18 Pages
From
Zydelig - Product Thumbnail Image

Zydelig

  • Report
  • 29 Pages
From
Treanda/Bendeka - Product Thumbnail Image

Treanda/Bendeka

  • Report
  • 58 Pages
From
Rituxan - Product Thumbnail Image

Rituxan

  • Report
  • 82 Pages
From
Ublituximab - Product Thumbnail Image

Ublituximab

  • Report
  • 43 Pages
From
lisocabtagene maraleucel - Product Thumbnail Image

lisocabtagene maraleucel

  • Report
  • 30 Pages
From
umbralisib - Product Thumbnail Image

umbralisib

  • Report
  • 26 Pages
From
Yescarta - Product Thumbnail Image

Yescarta

  • Report
  • 19 Pages
From
Zevalin - Product Thumbnail Image

Zevalin

  • Report
  • 17 Pages
From
From
From
From
Non-Hodgkin Lymphoma - Heat Map and Analysis - Product Thumbnail Image

Non-Hodgkin Lymphoma - Heat Map and Analysis

  • Drug Pipelines
  • 15 Pages
From
Loading Indicator

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

adroll